Press Release: Sanofi to acquire Qunol®, a fast-growing U.S. brand in the healthy aging segmentGlobeNewsWire • 07/28/23
Sanofi Consumer Healthcare North America Earns B Corp Certification in Recognition of Environmental, Social ImpactPRNewsWire • 07/25/23
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold seasonMarket Watch • 07/18/23
Press Release: FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV diseaseGlobeNewsWire • 07/17/23
Scribe Therapeutics Expands Collaboration with Sanofi to Advance In Vivo Genetic Medicines for Sickle Cell and Other Genomic DiseasesBusiness Wire • 07/17/23
SK bioscience-Sanofi Announce Positive Results from Phase II Study of 21-Valent Pneumococcal Conjugate Vaccine CandidatePRNewsWire • 06/29/23
Press Release: Vaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal diseaseGlobeNewsWire • 06/29/23
Sanofi (SNY) Atopic Dermatitis Drug Meets Goals in Phase II StudyZacks Investment Research • 06/28/23
Press Release: Positive topline Phase 2b data in atopic dermatitis support amlitelimab as a potential first and best-in-class novel investigational anti-OX40-ligand monoclonal antibodyGlobeNewsWire • 06/27/23
Press Release: ALTUVIIIO late-breaking data at ISTH demonstrates highly effective bleed protection in children with severe hemophilia A with once-weekly dosingGlobeNewsWire • 06/25/23
